Literature DB >> 10413656

Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity.

K Q Xin1, Y Lu, K Hamajima, J Fukushima, J Yang, K Inamura, K Okuda.   

Abstract

Cytokines play important roles in regulating immune response. This study evaluated the adjuvant effect of an expression plasmid encoding RANTES (regulated on activation normal T-cell expressed and secreted) chemokine on the immunity induced by a DNA vaccine. This vaccine consists of expression plasmids encoding the env and rev genes of human immunodeficiency virus type 1 (HIV-1). DNA vaccination with RANTES plasmid induced significantly higher titers of serum HIV-1-specific IgG and IgG2a antibodies than DNA vaccination alone on both intramuscular and intranasal immunization. This combination also increased HIV-1-specific cytotoxic T lymphocyte activity and delayed-type hypersensitivity. Intranasal immunization induced a higher titer of fecal secretory IgA antibody than intramuscular immunization. These results demonstrate that coadministration of RANTES plasmid dominantly induced HIV-1-specific cell-mediated immunity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413656     DOI: 10.1006/clim.1999.4730

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

Review 1.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specific immune response with DNA vaccines.

Authors:  Ruijiang Song; Shuqin Liu; Kam W Leong
Journal:  Mol Ther       Date:  2007-03-13       Impact factor: 11.454

4.  Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun.

Authors:  Kenneth C Bagley; George K Lewis; Timothy R Fouts
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

Review 5.  Cytokines: the future of intranasal vaccine adjuvants.

Authors:  Afton L Thompson; Herman F Staats
Journal:  Clin Dev Immunol       Date:  2011-07-31

Review 6.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.

Authors:  Lakshmi Ramakrishna; Krishnamurthy Kumar Anand; Kumarasamypet M Mohankumar; Udaykumar Ranga
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine.

Authors:  Sarah E Belisle; Jiangmei Yin; Devon J Shedlock; Anlan Dai; Jian Yan; Lauren Hirao; Michele A Kutzler; Mark G Lewis; Hanne Andersen; Simon M Lank; Julie A Karl; David H O'Connor; Amir Khan; Niranjan Sardesai; Jean Chang; Lauri Aicher; Robert E Palermo; David B Weiner; Michael G Katze; Jean Boyer
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

Review 9.  Modulation of HIV-1 immunity by adjuvants.

Authors:  M Anthony Moody
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

Review 10.  Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.

Authors:  Xiaoguang Wang; Delong Meng
Journal:  Protein Cell       Date:  2014-12-13       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.